HER2-Negative Breast Cancer Completed Phase 1 Trials for Vinorelbine (DB00361)

IndicationStatusPhase
DBCOND0072181 (HER2-Negative Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01104259Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerTreatment